Publications

Publications et chapitres de livres 2012-2016 :

Revues de langue anglaise

1)Piroth L, Launay O, Michel ML, Bourredjem A, Miailhes P, Ajana F, Chirouze C, Zucman D, Wendling MJ, Nazzal D, Carrat F, Rey D, Binquet C; ANRS HB EP03 CISOVAC Study Group. Vaccination Against Hepatitis B Virus (HBV) in HIV-1-Infected Patients With Isolated Anti-HBV Core Antibody: The ANRS HB EP03 CISOVAC Prospective Study. J Infect Dis. 2016 Jun 1;213(11):1735-42. doi: 10.1093/infdis/jiw011. Epub 2016 Jan 14.

2)Desbouys L, Grison S, Launay O, Loulergue P. Influenza vaccination competence of nurses in France: A survey in nursing schools. Am J Infect Control. 2016 Feb 1;44(2):236-8.

3)Bucher J, Boelle PY, Hubert D, Lebourgeois M, Stremler N, Durieu I, Bremont F, Deneuville E, Delaisi B, Corvol H, Bassinet L, Grenet D, Remus N, Vodoff MV, Boussaud V, Troussier F, Leruez-Ville M, Treluyer JM, Launay O, Sermet-Gaudelus I. Lessons from a French collaborative case-control study in cystic fibrosis patients during the 2009 A/H1N1 influenza pandemy. BMC Infect Dis. 2016 Feb 1;16(1):55.

4)Dinges W, Girard PM, Podzamczer D, Brockmeyer NH, García F, Harrer T, Lelievre JD, Frank I, Colin De Verdière N, Yeni GP, Ortega Gonzalez E, Rubio R, Clotet Sala B, DeJesus E, Pérez-Elias MJ, Launay O, Pialoux G, Slim J, Weiss L, Bouchaud O, Felizarta F, Meurer A, Raffi F, Esser S, Katlama C, Koletar SL, Mounzer K, Swindells S, Baxter JD, Schneider S, Chas J, Molina JM, Koutsoukos M, Collard A, Bourguignon P, Roman F. The F4/AS01B HIV-1 Vaccine Candidate Is Safe and Immunogenic, But Does Not Show Viral Efficacy in Antiretroviral Therapy-Naive, HIV-1-Infected Adults: A Randomized Controlled Trial. Medicine (Baltimore). 2016 Feb;95(6):e2673

5)Vieillard V, Gharakhanian S, Lucar O, Katlama C, Launay O, Autran B, Tsong Fang RH, Crouzet J, Murphy RL, Debré P. Perspectives for immunotherapy: which applications might achieve an HIV functional cure? Oncotarget. 2016 Feb 29. doi: 10.18632/oncotarget.7793. [Epub ahead of print]

6)Loubet P, Guerrisi C, Turbelin C, Blondel B, Launay O, Bardou M, Blanchon T, Bonmarin I, Goffinet F, Ancel PY, Colizza V, Hanslik T, Kernéis S. First nationwide web-based surveillance system for influenza-like illness in pregnant women: participation and representativeness of the French G-GrippeNet cohort. BMC Public Health. 2016 Mar 11;16(1):253.

7)Loubet P, Guerrisi C, Turbelin C, Blondel B, Launay O, Bardou M, Goffinet F, Colizza V, Hanslik T, Kernéis S; GGNET study group. Influenza during pregnancy: Incidence, vaccination coverage and attitudes toward vaccination in the French web-based cohort G-GrippeNet. Vaccine. 2016 Mar 21. pii: S0264-410X(16)30007-X. doi: 10.1016/j.vaccine.2016.03.034. 

8)Launay O, Rosenberg AR, Rey D, Pouget N, Michel ML, Reynes J, Neau D, Raffi F, Piroth L, Carrat F; ANRS HB03 VIHVAC-Long-term Immune Response to Hepatitis B Virus Vaccination Regimens in Adults With Human Immunodeficiency Virus 1: Secondary Analysis of a Randomized Clinical Trial.

JAMA Intern Med. 2016 Apr 11. doi: 10.1001/jamainternmed.2016.0741. 

9)Rondy M, Castilla J, Launay O, Costanzo S, Ezpeleta C, Galtier F, de Gaetano Donati K, Moren A. Moderate influenza vaccine effectiveness against hospitalisation with A(H3N2) and A(H1N1) influenza in 2013-14: Results from the InNHOVE network. Hum Vaccin Immunother. 2016 Feb 2:1-8. 

10)Loubet P, Samih-Lenzi N, Galtier F, Vanhems P, Loulergue P, Duval X, Jouneau S, Postil D, Rogez S, Valette M, Merle C, Régis C, Costa Y, Lesieur Z, Tattevin P, Lina B, Carrat F, Launay O; FLUVAC Study Group. Factors associated with poor outcomes among adults hospitalized for influenza in France: A three-year prospective multicenter study. J Clin Virol. 2016 Apr 12;79:68-73. doi: 10.1016/j.jcv.2016.04.005. 

11)Loulergue P, Kernéis S, Stern JB, Kassis-Chikani N, Derradji O, Escaut L, Launay O, Vittecoq D, Wyplosz B. Intention to vaccinate against influenza among health care workers caring for immunocompromised patients. Am J Infect Control. 2016 Apr 21. pii: S0196-6553(16)00242-X. doi: 10.1016/j.ajic.2016.02.030.

12)Loubet P, Loulergue P, Galtier F, Launay O. Seasonal influenza vaccination of high-risk adults. Expert Rev Vaccines. 2016 May 27:1-12. 

13)Launay O, Tsatsaris V. Maternal influenza immunisation in resource-limited settings. Lancet Infect Dis. 2016 May 31. pii: S1473-3099(16)30121-9. doi: 10.1016/S1473-3099(16)30121-9.

14)Rondy M, Launay O, Puig-Barberà J, Gefenaite G, Castilla J, de Gaetano Donati K, Galtier F, Hak E, Guevara M, Costanzo S; European hospital IVE network, Moren A. 2012/13 influenza vaccine effectiveness against hospitalised influenza A(H1N1)pdm09, A(H3N2) and B: estimates from a European network of hospitals Euro Surveill. 2015 Jan 15;20(2)

15)Hmamouchi I, Winthrop K, Launay O, Dougados M. Low rate of influenza and pneumococcal vaccine coverage in rheumatoid arthritis: data from the international COMORA cohort. Vaccine.2015;33(12):1446-52

16)Lemoine S, Jaron B, Tabka S, Ettreiki C, Deriaud E, Zhivaki D, Le Ray C, Launay O, Majlessi L, Tissieres P, Leclerc C, Lo-Man R. Dectin-1 activation unlocks IL12A expression and reveals the TH1 potency of neonatal dendritic cells. J Allergy Clin Immunol.  2015 Nov;136(5):1355-68.

17)Masson A, Launay O, Delaisi B, Bassinet L, Remus N, Lebourgeois M, Chedevergne F, Bailly C, Foucaud P, Corvol H, deBlic J, Sermet-Gaudelus I. Vaccine coverage in CF children: A French multicenter study J Cyst Fibros. 2015 Sep;14(5):615-20

18)Benoit A, Beran J, Devaster JM, Esen M, Launay O, Leroux-Roels G, McElhaney JE, Oostvogels L, van Essen GA, Gaglani M, Jackson LA, Vesikari T, Legrand C, Tibaldi F, Innis BL, Dewé W. Hemagglutination Inhibition Antibody Titers as a Correlate of Protection Against Seasonal A/H3N2 Influenza Disease. Open Forum Infect Dis. 2015 May 14;2(2)

19)Loubet P, Kerneis S, Groh M, Loulergue P, Blanche P, Verger P, Launay O. Attitude, knowledge and factors associated with influenza and pneumococcal vaccine uptake in a large cohort of patients with secondary immune deficiency. Vaccine. 2015 Jun 17;33(31):3703-8.

20)Mullaert J, Abgrall S, Lele N, Batteux F, Slama LB, Meritet JF, Lebon P, Bouchaud O, Grabar S, Launay O; ANRS VIHVO Study Group. Diphtheria, tetanus, poliomyelitis, yellow fever and hepatitis B seroprevalence among HIV1-infected migrants. Results from the ANRS VIHVO vaccine sub-study. Vaccine. 2015 Sep 11;33(38):4938-44.

21)Haviari S, Bénet T, Saadatian-Elahi M, André P, Loulergue P, Vanhems P. Vaccination of healthcare workers: A review. Hum Vaccin Immunother.  2015;11(11):2522-37

22)Launay O, Abitbol V, Krivine A, Ben Slama L, Bourreille A, Dupas JL, Hébuterne X, Savoye G, Deplanque D, Bouhnik Y, Pelletier AL, Galtier F, Laharie D, Nachury M, Zerbib F, Allez M, Bommelaer G, Duclos B, Lucht F, Gougeon ML, Tartour E, Rozenberg F, Hanslik T, Beaugerie L, Carrat F; MICIVAX Study Group. Immunogenicity and safety of influenza vaccine in inflammatory bowel disease patients treated or not with immunomodulators and/or biologics: a two-year prospective study. J Crohns Colitis.2015 Dec;9(12):1096-107 

23)Rey D, Piroth L, Wendling MJ, Miailhes P, Michel ML, Dufour C, Haour G, Sogni P, Rohel A, Ajana F, Billaud E, Molina JM, Launay O, Carrat F; ANRS HB04 B-BOOST study group. Safety and immunogenicity of double-dose versus standard-dose hepatitis B revaccination in non-responding adults with HIV-1 (ANRS HB04 B-BOOST): a multicentre, open-label, randomised controlled trial. Lancet Infect Dis. 2015 Nov;15(11):1283-91.

24)Iordache L, Launay O, Bouchaud O, Jeantils V, Goujard C, Boue F, Cacoub P, Hanslik T, Mahr A, Lambotte O, Fain O. Autoimmune diseases in HIV-Infected patients: 52 cases and literature review. Autoimmunity Reviews 2014;13(8):850-857

25)van Essen, Beran J, Devaster JM, Durand C, Duval X, Esen M, Falsey AR, Feldman G, Gervais P, Innis BL, Kovac M, Launay O, Leroux-Roels G, McElhaney JE, McNeil S, Oujaa M, Richardus JH, Ruiz-Palacios G, Osborne RH, Oostvogels L. Influenza symptoms and their impact on elderly adults: randomised trial of AS03-adjuvanted or non-adjuvanted inactivated trivalent seasonal influenza vaccines. Influenza and other Respiratory viruses 2014; 8(4): 452-462

26)Launay O, Le Strat Y, Tosini W, Kara L, Quelet S, Lévy S, Danan J, Réveillon J, Houdayer J, Bouvet E, Lévy-Bruhl D; The ANRS-FORMVAC Study Group. Impact of free on-site vaccine and/or healthcare workers training on hepatitis B vaccination acceptability in high-risk subjects: a pre-post cluster randomized study. Clin Microbiol Infect. 2014 May 22. doi: 10.1111/1469-0691.12689. [Epub ahead of print]

27)Launay O, Boelle PY, Krivine A, Grenet D, Boussaud V, Rémus N, Corvol H, Chedevergne F, Hubert D, Sermet-Gaudelus I; Inserm MUCOFLU group. Factors associated with humoral immune response to pandemic A/H1N1(v) 2009 influenza vaccine in cystic fibrosis. Vaccine. 2014 Jun 17 [Epub ahead of print]

28)Puig-Barberà J, Natividad-Sancho A, Launay O, Burtseva E, Ciblak MA, Tormos A, Buigues-Vila A, Martínez-Úbeda S, Sominina A; the GIHSN Group. 2012-2013 Seasonal Influenza Vaccine Effectiveness against Influenza Hospitalizations: Results from the Global Influenza Hospital Surveillance Network. PLoS One. 2014 Jun 19;9(6):e100497

29)Zhang X, Mozeleski B, Lemoine S, Dériaud E, Lim A, Zhivaki D, Azria E, Le Ray C, Roguet G, Launay O, Vanet A, Leclerc C, Lo-Man R. CD4 T cells with effector memory phenotype and function develop in the sterile environment of the fetus. Sci Transl Med. 2014 May 28;6(238)

30)Launay O, Le Strat Y, Tosini W, Kara L, Quelet S, Lévy S, Danan J, Réveillon J, Houdayer J, Bouvet E, Lévy-Bruhl D; The ANRS-FORMVAC Study Group.Impact of free on-site vaccine and/or healthcare workers training on hepatitis B vaccination acceptability in high-risk subjects: A pre-post cluster randomized study. Clin Microbiol Infect. 2014 May 22.  [Epub ahead of print]

31)Kerneis S, Launay O, Turbelin C, Batteux F, Hanslik T, Boelle PY. Long term Immune Responses to Vaccination in HIV-Infected Patients: A Systematic Review and Meta-Analysis. Clinical Infectious Diseases 2014;58(8):1130-1139

32)Desaint C, Durier C, Poda A, Krivine A, Simon F, Bodilis H, Pialoux G, Cuzin L, Poizot-Martin I, Morineau P, Lelievre JD, Silbermann B, Aboulker JP and Launay O. Long-Term Persistence of Vaccine-Induced HIV Seropositivity in Healthy Volunteers. J AIDS Clin Res 2014,5:275. 

33)Zhang X, Casartelli N, Lemoine S, Mozeleski B, Azria E, Le Ray C, Schwartz O, Launay O, Leclerc C, Lo-Man R. Plasmacytoid Dendritic Cells Engagement by Influenza Vaccine as a Surrogate Stategy for Driving T-Helper Type 1 Responses in Human Neonatal Settings. J Infect Dis. 2014 Mar 21. [Epub ahead of print]

34)Falsey AR, McElhaney JE, Beran J, van Essen GA, Duval X, Esen M, Galtier F, Gervais P, Hwang SJ, Kremsner P, Launay O, Leroux-Roels G, McNeil SA, Nowakowski A, Richardus JH, Ruiz-Palacios G, St Rose S, Devaster JM, Oostvogels L, Durviaux S, Taylor S. Respiratory Syncytial Virus and Other Respiratory Viral Infections in Older Adults With Moderate to Severe Influenza-like Illness. J Infect Dis. 2014 Jan 29. [Epub ahead of print]

35)Loulergue P, Launay O.Vaccinations among medical and nursing students: Coverage and opportunities. Vaccine. 2014 Feb 4.[Epub ahead of print]

36)N'Diaye DS, Yazdanpanah Y, Krivine A, Andrieu T, Rozenberg F, Picone O, Tsatsaris V, Goffinet F, Launay O. Predictive factors of cytomegalovirus seropositivity among pregnant women in Paris, France.
PLoS One. 2014 Feb 24;9(2)

37)Loison E, Poirier-Beaudouin B, Seffer V, Paoletti A, Abitbol V, Tartour E, Launay O, Gougeon ML. Suppression by thimerosal of ex-vivo CD4+T cell response to influenza vaccine and induction of apoptosis in primary memory T cells. PLoS One. 2014 Apr 1;9(4)

38)Wyplosz B, Burdet C, François H, Durrbach A, Duclos-Vallée JC, Mamzer-Bruneel MF, Poujol P, Launay O, Samuel D, Vittecoq D and Consigny PH for the GEVACCIM. Persistence of Yellow Fever Vaccine-Induced Antibodies After Solid Organ Transplantation. American Journal of Transplantation 2013;13:2458-2461

39)Launay O, Duval X, Fitoussi S, Jilg W, Kerdpanich A, Montellano M, Schwaz Tino F, Watanveerade V, Wenzel Jürgen J, Zalcman G, Bambure V, Li P, Caplanusi A, Madan A, Gillard P and Vaughn David W. Extended antigen sparing potential of AS03-adjuvanted pandemic H1N1 vaccines in children, and immunological equivalence of two formulations of AS03-adjuvanted H1N1vaccines: results from towo randomised trials. BMC Infectious Diseases 2013;13:435

40)Pilorgé L, Chartier M, Méritet JF, Cervantes M, Tsatsaris V, Launay O, Rozenberg F, Krivine A. Rhinoviruses as an Underestimated Cause of Influenza-Like Illness in Pregnancy During the 2009-2010 Influenza Pandemic. Journal of Medical Virology 2013, 85(8);1473-7

41)Loulergue P, Fonteneau L, Armengaud JB, Momcilovic S, Levy-Brühl D, Launay O, Guthmann JP, for the Studyvax survey group. Vaccine coverage of healthcare students working in hospitals of the Paris region, 2009: the STUDYVAX survey. Vaccine 2013; 10;31(26):2835-8

42)Launay O, Paul S, Servettaz A, Roguet G, Rozenberg F, Lucht F, Lambert C, Presles E, Goulvestre C, Méritet JF, Galtier F, Dubray C, Lebon P, Weill B, Batteux F. Control of humoral immunity and auto-immunity by the CXCR4/CXC.12 axis in lupus patients following influenza vaccine. Vaccine 2013; (31), 3492-3401

43)Kernéis S, Launay O, Ancelle T, Iordache L, Naneix-Laroche V, Naneix-Laroche V, Méchaï F, Fehr T, Leroy JP, Issartel B, Dunand J, Van Der Vliet D, Wyplosz B, Consigny PH, Hanslik T. Safety and Immunogenicity of Yellow Fever 17D Vaccine in Adults Receiving Systemic Corticosteroid Therapy: An Observational Cohort Study. Arthritis Care & Research 2013; (65), 1522-1528

44)Launay O, Surenaud M, Desaint C, Ben Hamouda N, Pialoux G, Bonnet B, Poizot Martin I, Gonzales G, Cuzin L, Bourgault Villada I, Lévy Y, Choppin J, Durier C. Long-term CD4+ and CD8+ T-cell responses induced in HIV-uninfected volunteers following intradermal or intramuscular administration of an HIV-lipopeptide vaccine (ANRS VAC 16). Vaccine 2013; 31, 4406-4415

45)Bonduelle O, Yahia N, Siberil S, Benhabiles N, Carrat F, Krivine A, Rozenberg F, Dimitrov J, Kaveri S, Curjol A, Tindel M, Louet M, Desert F, Launay O, Loulergue P, Badre G, Katlama C, Bricaire F, Samri A, Rousset D, Van der Werf S, Jauréguiberry S, Combadière B.
Longitudinal and Intergrative Biomodeling of Effector and Memory Immune Compartments after Inactivated Influenza Vaccination
The Journal of Immunology 2013;191(2):623-31

46)Launay O, Paul S, Servettaz A, Roguet G, Rozenberg F, Lucht F, Lambert C, Presles E, Goulvestre C, Meritet JF, Galtier F, Dubray C, Lebon P, Weill B, Batteux F.
Control of humoral immunity and auto-immunity by the CXCR4/CXCL12 axis in lupus patients following influenza vaccine
Vaccine 2013 2;31(35)

47)Durier C, Desaint C, Lucht F, Girard PM, Levy Y, May T, Michelet C, Rami A, Roman F, Delfraissy JF, Aboulker JP, Launay O.
Long-term immunogenicity of two doses of 2009 A/H1N1v vaccine with and without AS03(A) adjuvant in HIV-1-infected adults.
AIDS 2013;27(1), 87-93

48)Zhang XM, Lepelley A, Azria E, Lebon P, Roguet G, Schwartz O, Launay O, Leclerc C, Lo-Man R
Neonatal Plasmacytoid Dendritic Cells (pDCs) Display Subset Variation But Can Elicit Potent Anti-Viral Innate Responses
Plos One 2013;8(1) e52003

49)Rondy M, Puig-Barbera J, Launay O, Duval S, Castilla J, Guevara M, Costanzo S, Donati KD, Moren A. 2011-12 Seasonal Influenza Vaccines Effectiveness against Confirmed A(H3N2) Influenza Hospitalisation: Pooled Analysis from a European Network of Hospitals. A Pilot Study
Plos One 2013;8(4) e59681

50)Launay O, Duval X, Fitoussi S, Jilg W, Kerdpanich A, Montellano M, Schwarz TF, Watanveerade V, Wenzel JJ, Zalcman G, Bambure V, Li P, Caplanusi A, Madan A, Gillard P and Vaughn D W. Extended antigen sparing potential of AS03-adjuvanted pandemic H1N1 vaccines in children, and immunological equivalence of two formulations of AS03-adjuvanted H1N1 vaccines: results from two randomised trials. BMC Infectious Diseases 2013; 16,13(1):435

51)Laurichesse H, Zimmermann U, Galtier F, Launay O, Duval X, Richard P, Sadorge C, Soubeyrand B. Immunogenicity and safety results from a randomized multicenter trial comparing a Tdap-IPV vaccine (REPEVAX ®) and a tetanus monovalent vaccine in healthy adults: New considerations for the management of patients with tetanus-prone injuries
Hum Vaccin Immunother. 2012. 2;8(12)

52)Duval X, Caplanusi A, Laurichesse H, Deplanque D, Loulergue P, Vaman T, Launay O, Gillard P.
Flexibility of interval between vaccinations with AS03(A)-adjuvanted influenza A(H1N1) 2009 vaccine in adults aged 18-60 and sup 60 years: a randomized trial
BMC Infectious Diseases 2012;12(162)

53)Launay O, Krivine A, Charlier C, Truster V, Tsatsaris V, Lepercq J, Ville Y, Avenell C, Andrieu T, Artiguebielle F, Treluyer Jm, Goffinet F.
Low Rate of Pandemic A/H1N1 2009 Influenza Infection and Lack of Severe Complication of Vaccination in Pregnant Women: A Prospective Cohort Study
Plos One 2012;7(12) e52303

54)Hosmalin A, Amraoui S, DeRosa AL, Jourdain JP, Vimeux L, Goujard C, Loulergue P, Launay O, Richard Y, Dutertre CA.
M-DC8+monocyte expansion and TNFa overproduction in response to LPS during HIV-1 infection
Immunology 2012;137(SI):519-519

55)Rousseau B, Loulergue P, Mir O, Krivine A, Kotti S, Viel E, Simon T, de Gramont A, Goldwasser F, Launay O, Tournigand C.
Immunogenicity and safety of the influenza A H1N1v2009 vaccine in cancer patients treated with cytotoxic chemotherapy and/or targeted therapy: the VACANCE study
Annals of Oncology 2012;23 (2),450-457

56)Durier C, Desaint C, Lucht F, Girard PM, Lévy Y, May T, Michelet C, Rami A, Roman F, Delfraissy JF, Aboulker JP, Launay O; for the ANRS 151 study group and the REIVAC network.
Long term immunogenicity of two doses of 2009A/h1N1v vaccine with and without AS03A-adjuvant in HIV-1-infected adults: ANRS 151 Randomized HIFLUVAC Trial. 
AIDS 2012 Sep 26 [Epub ahead of print]

57)Rivière Y, Montange T, Janvier G, Marnata C, Durrieu L, Chaix ML, Isaguliants M, Launay O, Bresson JL and Pol S. Hepatitis C virus-specific cellular immune responses in individuals with no evidence of infection Virology Journal 2012, 9:76

58)Scotto M, Afonso G, Larger E, Raverdy C, Lemonnier FA, Carel JC, Dubois-Laforgue D, Baz B, Levy D, Gautier JF, Launay O, Bruno G, Boitard C, Sechi LA, Hutton JC, Davidson HW, Mallone R.
Zinc transporter (ZnT)8186-194 is an immunodominant CD8+ Tcell epitope in HLA-A2+ type 1 diabetic patients.
Diabetologia 2012; 55(7):2026-2031

59)Scotto M, Afonso G, Osterbye T, Larger E, Luce S, Raverdy C, Novelli G, Bruno G, Gonfroy-Leymarie C, Launay O, Lemaonnier FA, Buus S, Carel JC, Boitard C, Mallone R.
HLA-B7-Restricted Islet Epitopes Are Differentially Recognized in Type 1 Diabetic Children and Adults and Form Weak Peptide-HLA Complexes
Diabetes 2012; 61(10):2546-2555

60)Dutertre CA, Amraoui S, Derosa A, Jourdain JP, Vimeux L, Goguet M, Degrelle S, Feuillet V, Liovat AS, Müller-Trutwin M, Decroix N, Deveau C, Meyer L, Goujard C, Loulergue P, Launay O, Richard Y, Hosmalin A.
Pivotal role of M-DC8+ monocytes from viremic HIV-infected patients in TNFα overproduction in response to microbial products.
Blood 2012; 13,120(11):2259-68

61)Phung B-C, Launay O.
Vaccination against viral hepatitis of HIV-1 infected patients.
Hum Vaccin Immunother. 2012  1;8(5):554-9

62)D'Alessandro E, Hubert D, Launay O, Bassinet L, Lortholary O, Jaffre Y, Sermet-Gaudelus I.
Determinants of Refusal of A/H1N1 Pandemic Vaccination in a High Risk Population: A Qualitative Approach
PloS One. 2012;7(4)e34054

63)Chauvat A, Benhamouda N, Loison E, Gougeon ML, Gey A, Levionnois E, Ravel P, Abitbol V, Roncelin S, Marcheteau E, Quintin-Colonna F, Fridmann WH, Launay O, Tartour E.
Pitfalls in anti-influenza T cell detection by Elispot using thimerosal containing pandemic H1N1 vaccine as antigen
Journal of Immunological Methods 2012 Feb 16. [Epub ahead of print]

  

Revues de langue française

1)Anselem O, Parat S, Theau A, Floret D, Tsatsaris V, Goffinet F, Launay O. Vaccination and pregnancy. Presse Medicale 2014; 43(6):715-721

2)Aubert M, Aumaître H, Beytout J, Bloch K, Bouhour D, Callamand P, Chave C, Cheymol J, Combadière B, Dahlab A, Denis F, De Pontual L, Dodet B, Dommergues MA, Dufour V, Gagneur A, Gaillat J, Gaudelus J, Gavazzi G, Gillet Y, Gras-le-Guen C, Haas H, Hanslik T, Hau-Rainsard I, Larnaudie S, Launay O, Lorrot M, Loulergue P, Malvy D, Marchand S, Picherot G, Pinquier D, Pulcini C, Rabaud C, Rengnier F, Reinert P, Sana C, Savagner C, Soubeyrand B, Stephan JL, Strady C.
Current events in vaccination.
Arch Pediatr. 2011 Nov;18(11):1234-46

3)Anselem O, Tsatsaris V, Lopez E, Krivine A, Le Ray C, Loulergue P, Floret D, Goffinet F, Launay O.
Measles and Pregnacy
Presse Med. 2011; 40:1001-1007

4)Duchet-Niedziolka P, Hanslik T, Mouthon L, Guillevin L, Launay O.
Flu vaccine and auto-immune and/or inflammatory diseases.
Presse Med. 2011 Jan 11[Epub ahead of print]

4)Aubert M, Aumaître H, Beytout J, Bloch K, Bouhour D, Callamand P, Chave C, Cheymol J, Combadière B, Dahlab A, Denis F, De Pontual L, Dodet B, Dommergues MA, Dufour V, Gagneur A, Gaillat J, Gaudelus J, Gavazzi G, Gillet Y, Gras-le-Guen C, Haas H, Hanslik T, Hau-Rainsard I, Larnaudie S, Launay O, Lorrot M, Loulergue P, Malvy D, Marchand S, Picherot G, Pinquier D, Pulcini C, Rabaud C, Regnier F, Reinert P, Sana C, Savagner C, Soubeyrand B, Stephan JL, Strady C.
Current events in vaccination.
Med Mal Infect. 2011 Apr 12. [Epub ahead of print]

5)Group Avancées Vaccinales, Gaillat J.
Collaborators : Ajana F, Alain S, Angelin-Duclos C, Aumaitre H, Bregere P, Launay O, Parez N, Rogeaux O, Soubeyrand B, Strady C, Weil-Olivier C.
Impact of childhood immunization programs in 20th century France
Rev Prat. 2010 Oct 20;60(8):1044-8

6)Launay O
New Influenza A H1N1v: usefulness of immunization
Presse Med. 2010 39(1):6-9.

7)Launay O, Hoch D, Saint-Sardos C, Guillemot D. and participants of Round Table n∞6 of Giens XXV.
Vaccines: Specific Features, Simulation of Impact and Medico-Economic Modelling
Therapie 2010; Juillet-Ao˚t;65(4):357-365 (Epub 2010 Sep 21).

8)Charlier C, Launay O, Coignard-Biehler H, Lecuit M, Lortholary O
Pregnancy: a high risk factor in influenza infection.
Med Sci (Paris). 2010 26(1):100-4.

9)Bulifon S, Tsatsaris V, Goffinet F, Mignon A, Batteux F, Delfraissy JF, Launay O.
Pandémie Grippale A/H1N1v, Grossesse et Vaccination.
Med Mal Infect. 2010; Sep 8 (Epub ahead of print)

10)Yvette Hénin, Bénédicte de Boischevalier, Françoise Reboul-Salze, Jean-Luc Cracowski et Christian Dualé pour le Groupe de Travail "Ethique" du Réseau National des Centres d'Investigation Clinique.
Aide à la rédaction du document écrit destiné à l'information du participant à la Recherche BioMédicale et à l'attestation de son consentement éclairé.
Therapie 2010; Mars-Avril 2010; 65(2):71-94

11)Dubar G, Launay O, Batteux F, Tsatsaris V, Goffinet F, Mignon A.
Pregnancy and pandemic influenza A(H1N1) 2009. Current concepts for anaesthesia and critical care medicine.
Ann Fr Anesth Reanim 2010.Feb;29(2):126-34


 

Page lue en 0,0066 seconde (5/0)